JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: 'signaling pathways cardiovascular {{media url='

Search results for: 'signaling pathways cardiovascular {{media url='

A3005 CAL-101 (Idelalisib, GS-1101)
2 Citation

Target: PI3K

Summary: PI3K inhibitor
A3006 GDC-0068 (RG7440)

Target: Akt

Summary: Pan-AKT inhibitor,highly selective

≥22.9 mg/mL
A3010 MK-2206 dihydrochloride
21 Citation

Target: Akt

Summary: Akt1/2/3 inhibitor

insoluble in EtOH; ≥12.01 mg/mL
A3015 BKM120
1 Citation

Target: PI3K

Summary: Inhibitor of pan-Class I PI3K

≥20.52 mg/mL
A3135 A-443654

Summary: Akt inhibitor,potent and selective

insoluble in H2O; ≥19.85 mg/mL
A3149 AKT inhibitor VIII
2 Citation

Target: Akt

Summary: Allosteric Akt kinase inhibitor

insoluble in H2O; insoluble in EtOH; ≥9.2 mg/mL
A3199 AT7867 dihydrochloride

Summary: Akt1 and p70S6K/PKA inhibitor

Soluble in DMSO
A3238 BEZ235 Tosylate
1 Citation

Summary: MTOR/P13K inhibitor

Soluble in DMSO
A3432 GDC-0941 dimethanesulfonate

Summary: PI3K inhibitor

insoluble in H2O; insoluble in EtOH; ≥207.6 mg/mL
A3674 NVP-BKM120 Hydrochloride

Summary: PI3K inhibitor

≥44.7 mg/mL